东阳光集团旗下核心医药平台——东阳光药成功通过香港联合交易所聆讯,即将实现东阳光药业板块一体化。这不仅是东阳光药发展历程中的重要里程碑,更是东阳光集团二十余载矢志不渝深耕医药健康产业,以创新为引擎驱动发展的辉煌见证。廿载坚守,厚植医药创新沃土。自投身医药领域以来,东阳光人呕心沥血,始终将研发创新视为生命线,持续投入巨量资源,构建起涵盖肿瘤、抗病毒、内分泌及代谢、心血管等重大疾病领域的强大研发体系与...
Source Link东阳光集团旗下核心医药平台——东阳光药成功通过香港联合交易所聆讯,即将实现东阳光药业板块一体化。这不仅是东阳光药发展历程中的重要里程碑,更是东阳光集团二十余载矢志不渝深耕医药健康产业,以创新为引擎驱动发展的辉煌见证。廿载坚守,厚植医药创新沃土。自投身医药领域以来,东阳光人呕心沥血,始终将研发创新视为生命线,持续投入巨量资源,构建起涵盖肿瘤、抗病毒、内分泌及代谢、心血管等重大疾病领域的强大研发体系与...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.